Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin

@article{Sjogren2007AntiviralRO,
  title={Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin},
  author={Maria H. Sjogren and Robert Sjogren and Michael F. Lyons and Michael B Ryan and John S Santoro and Coleman Smith and Rajander K Reddy and Herbert L. Bonkovsky and Brooke Huntley and Sima Faris-Young},
  journal={Digestive Diseases and Sciences},
  year={2007},
  volume={52},
  pages={1540-1547}
}
Achieving an antiviral response at a reasonable cost is a challenge in the treatment of patients with chronic hepatitis C. A previous study indicated that consensus interferon with ribavirin had promising activity against hepatitis C virus (HCV) genotype 1. The objective of this study was to determine the virologic response with consensus interferon or pegylated interferon α-2b plus weight-ribavirin in patients chronically infected with HCV genotype 1. Intention-to-treat analysis showed… CONTINUE READING